Company Filing History:
Years Active: 2014-2015
Title: Inventor Spotlight: Robert Torka
Introduction
Robert Torka is a notable inventor located in Kaufering, Germany. With a total of two patents to his name, he has made significant contributions in the field of pharmaceuticals, particularly in the creation of compounds aimed at treating serious medical conditions.
Latest Patents
His latest patents focus on quinolinyloxyphenylsulfonamides and their stereoisomeric forms, including solvates, hydrates, and pharmaceutically acceptable salts. These compounds are developed as pharmaceutical compositions that work in conjunction with carriers, excipients, or diluents. The primary utility of these quinolinyloxyphenylsulfonamides lies in their ability to aid in the prophylaxis, treatment, and after-treatment of hyperproliferative disorders, such as cancer and tumors, particularly effective against cancer metastases.
Career Highlights
Robert Torka is associated with the Max Planck Society for the Advancement of Science, an esteemed research institution known for its contributions to science and technology. His work demonstrates a commitment to advancing medical solutions through innovative pharmaceutical research.
Collaborations
Throughout his career, Robert has collaborated with eminent researchers in the field, including Axel Ullrich and Yixiang Zhang. These collaborations likely enhance the research potential and efficacy of the projects he undertakes, driving forward advancements in the medical and pharmaceutical landscapes.
Conclusion
Robert Torka stands out as a dedicated inventor whose work has vital implications for the treatment of serious health issues. His innovative patents on quinolinyloxyphenylsulfonamides reflect his commitment to improving therapeutic options for patients battling hyperproliferative disorders, showcasing the impactful nature of his contributions to science.